Fast Five Quiz: What Do You Know About Psoriasis?

Dirk M Elston, MD; William James, MD


January 25, 2023

Because there are no evidence-based studies on duration of the interval between discontinuation of a previous therapy and a new biologic, treatment decisions should depend on the treatment that is being discontinued, disease severity, and response to prior treatment.

Other recommendations for the treatment of moderate to severe plaque psoriasis include the use of etanercept, infliximab, adalimumab, or ustekinumab as monotherapy or combined with other agents.

Learn more about the treatment of psoriasis.

Editor's Recommendations


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.